Stock Events

Stock Events

InMed Pharmaceuticals 

C$0.060000
39
-C$0.01-14.29%Friday 19:15

Statistics

Day High
0.06
Day Low
0.06
52W High
0.1
52W Low
0.06
Volume
18,000
Avg. Volume
-
Mkt Cap
32,962.38
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 3Expected
Q1 2025
Next
-27.02
-26.69
-26.36
-26.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-408%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.44MRevenue
-18.11MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IN.TO. It's not an investment recommendation.
Bitcoin
5
BTC.CRYPTO
AGNC Investment
5
AGNC
Meta Platforms
5
META
Gamestop
5
GME

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap81.62M
Corbus Pharmaceuticals specializes in the development of drugs targeting inflammatory and fibrotic diseases, overlapping with InMed's therapeutic areas.
Aurora Cannabis
ACB
Mkt Cap257.04M
Aurora Cannabis is a major player in the cannabis industry, whose expansion into medical cannabis products puts it in direct competition with InMed's pharmaceutical cannabis products.
Tilray Brands
TLRY
Mkt Cap373.9M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially competing with InMed in the medical cannabis market.
Canopy Growth
CGC
Mkt Cap276.03M
Canopy Growth Corporation operates in the cannabis and hemp business, competing with InMed in the development of cannabinoid-based pharmaceuticals.
Curaleaf
CURLF
Mkt Cap2.5B
Curaleaf Holdings operates in the cannabis retail and medical cannabis oil production, competing with InMed in the cannabinoid-based product market.

About

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Show More
CEO
Eric A. Adams Chem.
Employees
6
Country
Canada
ISIN
CA4576371062
WKN
000A42R7Q

Listings

MU
DE
MWG2.MU
F
DE
MWG.F
XNAS
US
INM
STU
DE
MWG.STU

0 Comments

Share your thoughts

FAQs

What is InMed Pharmaceuticals stock price today?▼
The current price of IN.TO is C$0.06 CAD — it has decreased by -14.29% in the past 24 hours. Watch InMed Pharmaceuticals stock price performance more closely on the chart.
What is InMed Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Toronto Exchange exchange InMed Pharmaceuticals stocks are traded under the ticker IN.TO.
What is InMed Pharmaceuticals market cap?▼
Today InMed Pharmaceuticals has the market capitalization of 32,962.38
When is the next InMed Pharmaceuticals earnings date?▼
InMed Pharmaceuticals is going to release the next earnings report on February 16, 2027.
What is InMed Pharmaceuticals revenue for the last year?▼
InMed Pharmaceuticals revenue for the last year amounts to 4.44M CAD.
What is InMed Pharmaceuticals net income for the last year?▼
IN.TO net income for the last year is -18.11M CAD.
How many employees does InMed Pharmaceuticals have?▼
As of November 7, 2026, the company has 6 employees.
In which sector is InMed Pharmaceuticals located?▼
InMed Pharmaceuticals operates in the Health & Wellness sector.
When did InMed Pharmaceuticals complete a stock split?▼
The last stock split for InMed Pharmaceuticals was on July 6, 2020 with a ratio of 1:33.
Where is InMed Pharmaceuticals headquartered?▼
InMed Pharmaceuticals is headquartered in VANCOUVER, Canada.